Coronavirus Vaccine: How The U.S. Snagged A Third Of AstraZeneca's DosesInvestors Business Daily • 05/21/20
AstraZeneca's Lynparza Label Expansion, And Other News: The Good, Bad And Ugly Of BiopharmaSeeking Alpha • 05/21/20
AstraZeneca receives $1 billion in US funding for Oxford University coronavirus vaccineCNBC • 05/21/20
AstraZeneca signs first agreements to deliver at least 400 million doses of COVID-19 vaccineInvezz • 05/21/20
AstraZeneca says it can produce 1 billion doses of Oxford's potential COVID-19 vaccineMarket Watch • 05/21/20
U.S. FDA approves AstraZeneca and Merck’s Lynparza as a treatment for prostate cancerInvezz • 05/20/20
These 6 Coronavirus Vaccine Candidates Are The Likeliest To Succeed, Says Morgan StanleyBenzinga • 05/18/20
LOGC FINAL DEADLINE TODAY: ROSEN, NATIONAL TRIAL LAWYERS, Reminds LogicBio Investors of Important Deadline in Securities Class Action - LOGCPRNewsWire • 05/18/20
From Gilead To AstraZeneca, Investors Should Watch These Biotech Giants Right NowThe Motley Fool • 05/07/20
AstraZeneca PLC (AZN) CEO Pascal Soriot on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 04/29/20